Venmax Drugs and Pharmaceuticals Ltd

BSE: 531015

total announcements

531015.BO · 15 min delayed

BSEBoard MeetingResults4d ago

Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited ....

Venmax Drugs and Pharmaceuticals Ltd has scheduled a board meeting on August 7, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026, and to consider the forfeiture of partly paid-up share warrants.

Allotment of 7,53,334 Convertible warrants in to Equity Shares on Preferential basis pursuant to Regulation 30 read with schedule III of SEBI LODR Regulation, 2015.

Venmax Drugs and Pharmaceuticals Ltd has allotted 7,53,334 equity shares to a warrant holder, Dinesh Muddu Kotian, at an issue price of Rs. 20 per share, increasing the company's paid-up capital to Rs. 14,48,39,290.

Allotment of 21,47,665 Convertible warrants in to Equity shares on preferential basis pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulation, 2015.

Venmax Drugs and Pharmaceuticals Ltd has allotted 21,47,665 equity shares to 8 warrant holders on a preferential basis, increasing the company's paid-up capital to Rs. 13,73,05,950.